Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 Investor Brand Network - Thu Oct 31, 9:00AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI) will showcase its inflammation and immunology (“I&I”) product pipeline and contract development and manufacturing (“CDMO”) services at the BIO-Europe 2024...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Schedules Virtual Panel Discussion Investor Brand Network - Tue Sep 17, 11:51AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) CEO Featured on Latest Episode of BioMedWire Podcast Investor Brand Network - Tue Sep 10, 8:15AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement Investor Brand Network - Thu Aug 22, 8:59AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement Investor Brand Network - Wed Aug 21, 8:03AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Q2 2024 Financial Results Investor Brand Network - Fri Aug 16, 10:23AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Receives PEI Feedback Regarding Anti-IL-17 NanoAb Investor Brand Network - Wed Jul 24, 9:51AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Receives Updated LOI from European Investment Bank Investor Brand Network - Tue Jul 9, 10:32AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases Q1 2024 Financial Reports Investor Brand Network - Tue Jul 2, 11:15AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

AMD : 141.17 (+0.33%)
SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases FY 2023 Financial Results Investor Brand Network - Fri May 17, 10:57AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

SCNI : 3.66 (+0.14%)

Barchart Exclusives

Should You Buy Meta Platforms Stock After Earnings? Barchart - 35 minutes ago
Despite crushing broader market returns in the past two years, Meta Platforms stock still trades at a reasonable valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot